DJIA 17,959.44 154.64 0.87%
NASDAQ 4,781.42 16.04 0.34%
S&P 500 2,078.54 7.89 0.38%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)



company name or ticker

Why Is George Soros Buying This Beaten Down Biotech Stock?

Soros Fund Management opened a position in the struggling biotech Aegerion Pharmaceuticals in the third quarter, even while the drugmaker's revenue estimates continued to plummet. Should retail investors follow his lead into this beaten down biotech?

Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog

Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog

2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses

Twitter's Favorite Biotech and Pharma Stocks

Consensus? We don't need no stinking consensus!

Does George Soros Think Biotech's Bull Run Is Finally Coming to an End?

The Soros Fund Managment sold off a number of biotechs in the third quarter. Do the actions of this closely watched fund signal that the industry's bull run is finally winding down?

Stocks Hitting 52-Week Lows

With Mid-2015 NDA Submission, Sarepta Can Rise

The 3 Most Memorable Moments in Healthcare This Year

Three Motley Fool analysts tell investors what they believe are the year's most memorable events in the healthcare sector.

Biotech Stock Mailbag: Aethlon Medical, Oxigene, Sarepta

Rolling with Biotech’s Regulatory Punches: Chen Lin

See More Articles...